Cathepsin l is associated with proliferation and clinical outcome of urothelial carcinoma of the bladder

Journal of International Medical Research

Volumn 38, Issue 6, 2010, Pages 1913-1922

  Yan, J A ^a   Xiao, H ^b   Ji, H X ^a   Shen, W H ^a   Zhou, Z S ^a   Song, B ^a   Chen, Z W ^a   Li, W B ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b The 324th Hospital of the Chinese People's Liberation Army   (China)

Author keywords

Cathepsin l; Immunohistochemistry; Ki 67; Prognosis; Urothelial carcinoma of the bladder

Indexed keywords

CATHEPSIN L; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSITIONAL CELL CARCINOMA;

EID: 78650844469     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800604     Document Type: Article

References (20)

1. Simon MA, Lokeshwar VB, Soloway MS: Current bladder cancer tests: unnecessary or beneficial? Crit Rev Oncol Hematol 2003; 47: 91-107.
2. Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-675.
3. Duffy MJ: The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992; 10: 145-152.
4. Bell-McGuinn KM, Garfall AL, Bogyo M, et al: Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer. Cancer Res 2007; 67: 7378-7385.
5. Mason RW: Emerging functions of placental cathepsins. Placenta 2008; 29: 385-390.
6. Brix K, Dunkhorst A, Mayer K, et al: Cysteine cathepsins: cellular roadmap to different functions. Biochimie 2008; 90: 194-207.
7. Collette J, Bocock JP, Ahn K, et al: Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L. Int Rev Cytol 2004; 241: 1-51.
8. Nomura T, Katunuma N: Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005; 52: 1-9.
9. Kuester D, Lippert H, Roessner A, et al: The cathepsin family and their role in colorectal cancer. Pathol Res Pract 2008; 204: 491-500.
10. Beaujouin M, Liaudet CE: Cathepsin D overexpressed by cancer cells can enhance apoptosis dependent chemo-sensitivity independently of its catalytic activity. Adv Exp Med Biol 2008; 617: 453-461.
11. Goulet B, Sansregret L, Leduy L, et al: Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 2007; 5: 899-907.
12. Zajc I, Hreljac I, Lah T: Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics. Anticancer Res 2006; 26: 3357-3364.
13. Hashimoto Y, Kondo C, Kojima T, et al Significance of 32-kDa cathepsin L secreted from cancer cells. Cancer Biother Radiopharm 2006; 21: 217-224.
14. Mostofi FK, Sobin LH, Torloni H: Histological Typing of Urinary Bladder Tumors. International Histological Classification of Tumors, No. 10. Geneva: World Health Organization, 1973.
15. Kayser K, Richter N, Hufnagl P, et al: Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer. Anticancer Res 2003; 23: 2767-2772.
16. Macabeo-Ong M, Shiboski CH, Silverman S, et al: Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression. Oral Oncol 2003; 39: 638-647.
17. Nasu K, Kai K, Fujisawa K, et al: Expression of cathepsin L in normal endometrium and endometrial cancer. Eur J Obstet Gynecol Reprod Biol 2001; 99: 102-105.
18. Farinati F, Herszényi L, Plebani M, et al: Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis. Carcinogenesis 1996; 17: 2581-2587.
19. Sivaparvathi M, Yamamoto M, Nicolson GL, et al: Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Clin Exp Metastasis 1996; 14: 27-34.
20. Thomssen C, Schmitt M, Goretzki L, et al: Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. Clin Cancer Res 1995; 1: 741-746